This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Oxford University Innovation Ltd, The Institute of Cancer Research: Royal Cancer Hospital, University of Leeds. Active years: 2023-2025.
Company Filing History:
1 out of 483 
1 out of 54 
1 out of 112 
Years Active: 2023-2025
Title: Philip Spencer Fallon: Innovator in Anticoagulant Research
Introduction
Philip Spencer Fallon is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulants. With a total of 3 patents to his name, Fallon has focused on innovative compounds that have the potential to impact medical treatments.
Latest Patents
Fallon's latest patents include advancements in Factor XIIA inhibitors. This invention relates to compounds of formula (I) and methods of treatment using these compounds. The invention also encompasses processes and methods for producing the compounds. The compounds are modulators of Factor XII, specifically Factor XIIa, and are particularly useful as anticoagulants. Additionally, he has developed compounds that are relevant for treating proliferative disorders, such as cancer, and other diseases where inhibition of a RAS-effector protein-protein interaction is implicated.
Career Highlights
Throughout his career, Fallon has worked with esteemed institutions such as the University of Leeds and the Institute of Cancer Research: Royal Cancer Hospital. His work in these organizations has allowed him to contribute to significant advancements in cancer research and treatment methodologies.
Collaborations
Fallon has collaborated with notable colleagues, including Anna Hopkins and Natalie Louise Winfield. These partnerships have fostered a collaborative environment that enhances the research and development of innovative medical solutions.
Conclusion
Philip Spencer Fallon is a distinguished inventor whose work in anticoagulant research and pharmaceutical innovations has the potential to transform medical treatments. His contributions are invaluable to the ongoing fight against diseases such as cancer.